Evidence map›Paper›PMID 41931615›Full record

ArticleScience advances2026

Posttranscriptional reprogramming controls MASLD progression through chronic ER stress adaptation.

Eulalia Belloc, Vittorio Calderone, Salvador Naranjo-Suarez, Lidia Mateo, Judit Martin, Florencia Malizia, Annarita Sibilio, Veronica Chanes, Marta Ramirez-Pedraza, M Eugenia Delgado and 9 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Eulalia BellocInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.ORCID 0000-0002-1059-3546
Vittorio CalderoneInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.ORCID 0009-0009-6494-2287
Salvador Naranjo-SuarezFRCB-IDIBAPS Biomedical Research Institute, 08036 Barcelona, Spain.ORCID 0000-0002-7038-0753
Lidia MateoInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.ORCID 0000-0002-9076-4025
Judit MartinInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.ORCID 0000-0002-4193-7890
Florencia MaliziaInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.
Annarita SibilioInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.ORCID 0000-0002-2496-8783
Veronica ChanesInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.ORCID 0000-0001-7280-1884
Marta Ramirez-PedrazaFRCB-IDIBAPS Biomedical Research Institute, 08036 Barcelona, Spain.ORCID 0000-0003-2135-4935
M Eugenia DelgadoFRCB-IDIBAPS Biomedical Research Institute, 08036 Barcelona, Spain.ORCID 0000-0002-8653-1819
Uta DrebberDepartment of Pathology, University Hospital of Cologne and Center for Molecular Medicine, University of Cologne, 50937 Cologne, Germany.ORCID 0000-0002-2697-4685
Karl-Peter RheinwaltDepartment of Bariatric, Metabolic, and Plastic Surgery, St. Franziskus-Hospital, 50825 Cologne, Germany.ORCID 0000-0001-9375-874X
Sabine KleinDepartment of Internal Medicine B, University of Münster, 48149 Münster, Germany.ORCID 0000-0001-6691-2895
Maximilian Joseph BrolDepartment of Internal Medicine B, University of Münster, 48149 Münster, Germany.ORCID 0000-0003-2879-7560
Robert SchierwagenDepartment of Internal Medicine B, University of Münster, 48149 Münster, Germany.ORCID 0000-0002-2195-3666
Jonel TrebickaDepartment of Internal Medicine B, University of Münster, 48149 Münster, Germany.ORCID 0000-0002-7028-3881
Patrick AloyInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.ORCID 0000-0002-3557-0236
Mercedes FernandezFRCB-IDIBAPS Biomedical Research Institute, 08036 Barcelona, Spain.ORCID 0000-0002-5270-4304
Raul MendezInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.ORCID 0000-0002-1952-6905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic dysfunction-associated steatohepatitis (MASH) and its progression to hepatocellular carcinoma remain major clinical challenges. Chronic endoplasmic reticulum (ER) stress, induced by sustained high-fat diet (HFD) intake, promotes hepatic inflammation, lipid accumulation, and hepatocellular dysfunction during MASH pathogenesis. While transcriptional responses are well characterized, the posttranscriptional mechanisms underlying hepatocyte adaptation to chronic ER stress remain poorly understood. Using an integrative approach combining transcriptomics, ribosome profiling, cytoplasmic polyadenylation analysis, and cis-regulatory mapping, we define the posttranscriptional landscape induced by chronic HFD exposure. To delineate the specific role of chronic ER stress, we use a hepatocyte-specific knockout of a key regulator of translational control under prolonged ER stress. We show that ~70% of HFD-induced gene expression changes are modulated at the translational level. A distinct subset of mRNAs, enriched in suboptimal codons and bearing short poly(A) tails under normal diet, becomes selectively activated upon HFD-induced poly(A) tail elongation. These transcripts, associated with cell cycle, immune response, fibrosis, and tissue remodeling, correlate with MASH severity in both murine models and human samples. Their regulation is mediated by cis-elements in the 3' UTR that coordinate polyadenylation and deadenylation. Loss of this adaptive response exacerbates liver damage and tumor burden in HFD-fed mice.

Indexed as

Adaptation, PhysiologicalEndoplasmic Reticulum StressNon-alcoholic Fatty Liver DiseaseRNA Processing, Post-TranscriptionalAnimalsDiet, High-FatDisease ProgressionGene Expression RegulationHepatocytesHumansMaleMicePolyadenylationRibosome ProfilingRNA, MessengerRNA, Messenger

Identifiers

PMID41931615
PMCPMC13048267

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.